DAVE

The sales reported in this row were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 10, 2025.

Represents a bona fide gift to a charitable organization.

The sales reported in this row were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 10, 2025.

Represents shares of Class A Common Stock underlying a restricted stock unit award ("RSU") granted under the Issuer's Amended and Restated 2021 Equity Incentive Plan in connection with annual awards to directors for service as a member of the Issuer's Board of Directors. The RSU will vest in full on the earlier of (i) June 2, 2027, and (ii) the date of the Issuer's next annual shareholder's meeting, subject to the Reporting Person's continued service as a member of the Board of Directors through such vesting date.

Shares of the Issuer's Class A Common Stock were sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's Class A Common Stock in connection with the settlement of the vested portion of restricted stock units.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $276.76 to $277.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Represents shares of Class A Common Stock underlying a restricted stock unit award ("RSU") granted under the Issuer's Amended and Restated 2021 Equity Incentive Plan in connection with annual awards to directors for service as a member of the Issuer's Board of Directors. The RSU will vest in full on the earlier of (i) June 2, 2027, and (ii) the date of the Issuer's next annual shareholder's meeting, subject to the Reporting Person's continued service as a member of the Board of Directors through such vesting date.

Represents shares of Class A Common Stock underlying a restricted stock unit award ("RSU") granted under the Issuer's Amended and Restated 2021 Equity Incentive Plan in connection with annual awards to directors for service as a member of the Issuer's Board of Directors. The RSU will vest in full on the earlier of (i) June 2, 2027, and (ii) the date of the Issuer's next annual shareholder's meeting, subject to the Reporting Person's continued service as a member of the Board of Directors through such vesting date.

Represents shares of Class A Common Stock underlying a restricted stock unit award ("RSU") granted under the Issuer's Amended and Restated 2021 Equity Incentive Plan in connection with annual awards to directors for service as a member of the Issuer's Board of Directors. The RSU will vest in full on the earlier of (i) June 2, 2027, and (ii) the date of the Issuer's next annual shareholder's meeting, subject to the Reporting Person's continued service as a member of the Board of Directors through such vesting date.

Shares of the Issuer's Class A Common Stock were sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's Class A Common Stock in connection with the settlement of the vested portion of restricted stock units.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $277.30 to $277.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Shares of the Issuer's Class A Common Stock were sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's Class A Common Stock in connection with the settlement of the vested portion of restricted stock units.

Shares of the Issuer's Class A Common Stock were sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's Class A Common Stock in connection with the settlement of the vested portion of restricted stock units.

Shares of the Issuer's Class A Common Stock were sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's Class A Common Stock in connection with the settlement of the vested portion of restricted stock units.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.27 to $275.01, inclusive.

Represents shares of Class A Common Stock underlying a restricted stock unit award ("RSU") granted under the Issuer's Amended and Restated 2021 Equity Incentive Plan in connection with annual awards to directors for service as a member of the Issuer's Board of Directors. The RSU will vest in full on the earlier of (i) June 2, 2027, and (ii) the date of the Issuer's next annual shareholder's meeting, subject to the Reporting Person's continued service as a member of the Board of Directors through such vesting date.

On May 29, 2026, the Reporting Person entered into a variable prepaid forward contract with an unaffiliated counterparty. The contract obligates the Reporting Person to deliver shares of Dave Inc. (the "Issuer") Class A Common Stock or, at the Reporting Person's election subject to certain conditions, settle the contract in cash, on a settlement date on or about June 15, 2028 (the "Maturity Date"). In exchange, the Reporting Person will receive an upfront cash payment of $5.2 million. The Reporting Person pledged 25,650 shares of the Issuer's Class A Common Stock (the "Subject Shares") to secure his obligations under the contract. The Reporting Person will retain all voting, dividend and other rights in the Subject Shares during the term of the pledge.

If the Reporting Person does not elect to settle the contract in cash, the number of shares of the Issuer's Class A Common Stock that may be delivered by the Reporting Person following the Maturity Date will generally be determined as follows: (a) if the closing price of shares of the Issuer's Class A Common Stock prior to the Maturity Date (the "Settlement Price") is less than $429.75 (the "Maximum Price") but greater than $220.39 (the "Minimum Price"), the Reporting Person will deliver a number of shares of the Issuer's Class A Common Stock equal to the Subject Shares multiplied by a ratio equal to the Minimum Price divided by the Settlement Price;

[Continued from footnote 2] (b) if the Settlement Price is equal to or greater than the Maximum Price on the Maturity Date, the Reporting Person will deliver a number of shares of the Issuer's Class A Common Stock equal to the Subject Shares multiplied by a ratio equal to a fraction with a numerator equal to the sum of (A) the Minimum Price and (B) the excess, if any, of the Settlement Price over the Maximum Price, and a denominator equal to the Settlement Price; and (c) if the Settlement Price is equal to or less than the Minimum Price on the Maturity Date, the Reporting Person will deliver a number of shares of the Issuer's Common Stock equal to the Subject Shares.

Represents shares of Class A Common Stock withheld by the Issuer to satisfy tax withholding upon the vesting of restricted stock units.

Reflects the number of performance-based restricted stock units ("PSUs") earned, as a result of the Compensation Committee's certification to the achievement of performance for the period from January 1, 2025 to December 31, 2025, under the terms of a PSU award granted on April 17, 2024. These shares will vest on June 1, 2027, subject to the Reporting Person's continued service through such vesting date.

Reflects the number of performance-based restricted stock units ("PSUs") earned, as a result of the Compensation Committee's certification to the achievement of performance for the period from January 1, 2025 to December 31, 2025, under the terms of a PSU award granted on April 17, 2024. These shares will vest on June 1, 2027, subject to the Reporting Person's continued service through such vesting date.

Reflects the number of PSUs earned, as a result of the Compensation Committee's certification to the achievement of performance for the period from January 1, 2025 to December 31, 2025, under the terms of a PSU award granted on April 11, 2025. These shares will vest on June 1, 2028, subject to the Reporting Person's continued service through such vesting date.

Represents shares of Class A Common Stock underlying a restricted stock unit ("RSU") award granted under the Issuer's Amended and Restated 2021 Equity Incentive Plan. The RSU will vest as to 1/8 of the total number of shares on June 1, 2026 and an additional 1/16 of the total number of shares on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each vesting date.

Represents shares of Class A Common Stock underlying a restricted stock unit ("RSU") award granted under the Issuer's Amended and Restated 2021 Equity Incentive Plan. The RSU will vest as to 1/8 of the total number of shares on June 1, 2026 and an additional 1/16 of the total number of shares on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each vesting date.

Reflects the number of PSUs earned, as a result of the Compensation Committee's certification to the achievement of performance for the period from January 1, 2025 to December 31, 2025, under the terms of a PSU award granted on April 11, 2025. These shares will vest on June 1, 2028, subject to the Reporting Person's continued service through such vesting date.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.95 to $210.85, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.88 to $206.81, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.88 to $207.87, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.16 to $214.97, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $208.88 to $209.77, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $211.97 to $212.91, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.34 to $205.33, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $216.39 to $216.96, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.38 to $215.88, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.88 to $208.73, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.95 to $211.79, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.07 to $214.03, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $216.59 to $217.51, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $212.19 to $213.12, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $211.05 to $212.03, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.19 to $222.22, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.21 to $223.22, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.03 to $211.00, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.00 to $219.56, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.39 to $215.37, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.39 to $215.95, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.00 to $209.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $217.69 to $218.63, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.04 to $220.22, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.10 to $222.04, inclusive.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.30 to $214.17, inclusive.

Represents shares of Class A Common Stock withheld by the Issuer to satisfy tax withholding upon the vesting of restricted stock units.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2025.

The exercise price and the number of securities reported herein have been adjusted to reflect the 1-for-32 reverse stock split effected by the Issuer on January 5, 2023.

The option vested 25% on July 15, 2019 and 1/48th monthly thereafter.